{"id":"W2012666111","doi":"10.1186/1758-2652-13-s4-o51","title":"Activity of the integrase inhibitor S/GSK1349572 in subjects with HIV exhibiting raltegravir resistance: week 24 results of the VIKING study (ING112961)","year":2010,"lang":"en","type":"article","venue":"Journal of the International AIDS Society","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Raltegravir; Integrase inhibitor; Medicine; Integrase; Pharmacology; Human immunodeficiency virus (HIV); Virology; Antiretroviral therapy; Viral load","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001376797,0.001065462,0.002232946,0.0004571048,0.0002455658,0.001191807,0.0007376419,0.001618089,0.003138368],"category_scores_gemma":[0.001277497,0.000616427,0.001552589,0.000411367,0.0004543984,0.0009211979,0.0002981528,0.003000816,0.0008873546],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006506559,"about_ca_system_score_gemma":0.0004695768,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001726181,"about_ca_topic_score_gemma":0.004088948,"domain_scores_codex":[0.999463,0.0002186845,0.00003275192,0.0001000573,0.00006701123,0.0001185119],"domain_scores_gemma":[0.99922,0.00016259,0.0002388317,0.00007708173,0.00004235214,0.0002590163],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7890742,0.007121606,0.0613646,0.0005241851,0.003115551,0.0003669572,0.0003000392,0.001618685,0.01981554,0.0001238709,0.00363883,0.112936],"study_design_scores_gemma":[0.2171712,0.3221425,0.4413159,0.0001799,0.004860586,0.0007395982,0.00028978,0.002234712,0.005306279,0.0003800027,0.005175304,0.0002042468],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9926998,0.0044357,0.00006743077,0.0002709334,0.00005934852,0.00008707037,0.001102724,0.00005184266,0.001225134],"genre_scores_gemma":[0.9951455,0.001336236,0.0001682428,0.0002775329,0.0000676103,0.00006918724,0.001065996,0.00001610053,0.001853654],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003138368,"threshold_uncertainty_score":0.01049888,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01349930354830394,"score_gpt":0.2601361236000707,"score_spread":0.2466368200517668,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}